Nancy Braman
Nancy Braman is a U.S. Registered Patent Agent and a 3L at UNH Franklin Pierce School of Law, where she serves as Senior Editor of IDEA: The Law Review of the Franklin Pierce Center for IP and a Teaching Assistant for Pretrial Advocacy. She is also a former author and researcher for IPWatchdog, Inc., to which she still enjoys contributing in her spare time.
Posts by Nancy Braman
Recent Trademark Developments: Four Cases Shaping the Law in the United States and Beyond
Trademark law has seen substantial developments in 2019 and 2020, with four major cases in the United States and Europe rising to the top. The U.S. Supreme Court (…
Federal Circuit says THE JOINT is merely descriptive without acquired distinctiveness
On February 28th, the Court of Appeals for the Federal Circuit (CAFC) affirmed the Trademark Trial and Appeal Board’s (TTAB) decision to refuse registration of two …
Amici Back Booking.com in Supreme Court Case Against USPTO
As argument nears in the Supreme Court battle between Booking.com and the United States Patent and Trademark Office (USPTO), 12 parties have now filed amicus briefs in …
Oracle Files Opening Brief at U.S. Supreme Court in Copyright Fight with Google
In the latest stage of the Supreme Court battle between Oracle America, Inc. (Oracle) and Google, Oracle filed its opening brief with the Court on February 12. Google’…
CAFC Rules PTAB Did Not Err in Finding Philips Patent Obvious in Light of General Knowledge of POSITA
On January 30, the Court of Appeals for the Federal Circuit (CAFC) affirmed the Patent Trial and Appeals Board’s (PTAB) decision rendering claims 1-11 of U.S. …
PTAB Holds Packet Filtering Claims Unpatentable in Cisco/Centripetal Networks IPR
On January 23, the Patent Trial and Appeal Board (PTAB) issued a final written decision holding all claims (1-20) of U.S. Patent No. 9,160,713 B2 (the ‘713 patent) unpatentable. …
CAFC Affirms District Court Finding that Hospira Precedex Patent Claim is Obvious
On January 9, the Court of Appeals for the Federal Circuit (CAFC) affirmed a decision of the U.S. District Court for the Northern District of Illinois, holding …
CAFC Reverses PTAB Non-Obviousness Decision in Finding for Google
On January 6, the U.S. Court of Appeals for the Federal Circuit (CAFC) reversed the Patent Trial and Appeal Board’s (PTAB) decision that Google failed to …
Amici Urge CAFC to Grant En Banc Review in American Axle Case
In October, the Court of Appeals for the Federal Circuit (CAFC) rejected a method for manufacturing propshafts in American Axle & Manufacturing (AAM) v. Neapco Holdings (Neapco), holding …
Federal Circuit Upholds $70 Million Judgment for Amgen in Epogen Biosimilar Case
Yesterday, in an opinion authored by Judge Moore, the Court of Appeals for the Federal Circuit (CAFC) affirmed the District of Delaware’s decision that: 1) U.S. …
Federal Circuit Affirms District Court’s Summary Judgment of NonInfringement Under the Doctrine of Equivalents
On November 22, the U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed a decision of the District of Nevada granting summary judgment of noninfringement under …
Professors Expand Upon Proposals to Senate IP Subcommittee for Improving Patent Quality
On October 30, the Senate Judiciary Committee’s Subcommittee on Intellectual Property heard from five witnesses on ways to improve patent quality at the United States Patent and …
CAFC Finds Columbia Patent Claims Invalid, Reverses Infringement Verdict
On November 13, the Court of Appeals for the Federal Circuit (CAFC) heard an appeal from the U.S. District Court for the Southern District of California in …
A Look at the Chrimar Amici: Inventors and IP Organizations Advocate for Rehearing En Banc as Federal Circuit Calls for ALE Response
Today, the U.S. Court of Appeals for the Federal Circuit (CAFC) invited ALE USA Inc. to respond to Chrimar System Inc.'s petition for rehearing en …
Federal Circuit Invalidity Determination for Idenix Underscores Continuing Intra-Circuit Split
One day before the now-famous Arthrex decision was issued, the U.S. Court of Appeals for the Federal Circuit (CAFC) decided an appeal by Idenix Pharmaceuticals LLC …
